CH608803A5 - - Google Patents

Info

Publication number
CH608803A5
CH608803A5 CH759692A CH969275A CH608803A5 CH 608803 A5 CH608803 A5 CH 608803A5 CH 759692 A CH759692 A CH 759692A CH 969275 A CH969275 A CH 969275A CH 608803 A5 CH608803 A5 CH 608803A5
Authority
CH
Switzerland
Application number
CH759692A
Inventor
John Christopher Danilewicz
Anthony Garth Ewans
Colin Thomson
Allan Leslie Ham
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CH608803A5 publication Critical patent/CH608803A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
CH759692A 1974-07-25 1975-07-24 CH608803A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25
GB41675*[A GB1460389A (en) 1974-07-25 1975-01-06 4-substituted quinazoline cardiac stimulants

Publications (1)

Publication Number Publication Date
CH608803A5 true CH608803A5 (fr) 1979-01-31

Family

ID=26235904

Family Applications (2)

Application Number Title Priority Date Filing Date
CH711378A CH611616A5 (fr) 1974-07-25 1975-07-24
CH759692A CH608803A5 (fr) 1974-07-25 1975-07-24

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH711378A CH611616A5 (fr) 1974-07-25 1975-07-24

Country Status (23)

Country Link
US (1) US4001422A (fr)
JP (1) JPS5527062B2 (fr)
AR (7) AR216046A1 (fr)
BG (2) BG27744A3 (fr)
CA (1) CA1060445A (fr)
CH (2) CH611616A5 (fr)
DD (1) DD119046A5 (fr)
DE (1) DE2530894C2 (fr)
DK (1) DK138800B (fr)
FI (1) FI66182C (fr)
FR (1) FR2279406A1 (fr)
GB (1) GB1460389A (fr)
HK (1) HK61879A (fr)
IE (1) IE41838B1 (fr)
IL (1) IL47625A (fr)
KE (1) KE2988A (fr)
LU (1) LU73072A1 (fr)
MY (1) MY8000108A (fr)
NL (1) NL159982C (fr)
PH (1) PH14190A (fr)
RO (3) RO71840A (fr)
SE (1) SE420921B (fr)
YU (3) YU37155B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (fr) 1977-06-03 1981-03-07 Pfizer
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
CA1086735A (fr) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
PE20030417A1 (es) * 2001-09-13 2003-08-06 Smithkline Beecham Plc Derivados de urea como antagonistas del receptor vainilloide
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
WO2004024710A1 (fr) * 2002-09-13 2004-03-25 Glaxo Group Limited Composes a base d'uree, actifs en tant qu'antagonistes du recepteur de la vanilloide et utilises pour traiter les douleurs
TWI350168B (en) 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
KR20070024639A (ko) * 2004-06-24 2007-03-02 인사이트 산 디에고 인코포레이티드 아미도 화합물 및 약제로서의 이의 용도
US7687665B2 (en) * 2004-06-24 2010-03-30 Incyte Corporation 2-methylprop anamides and their use as pharmaceuticals
JP2008504279A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
BRPI0512535A (pt) * 2004-06-24 2008-03-25 Incyte Corp compostos de piperidinas n-substituìdas, suas composições e métodos de modulações
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
US20060122197A1 (en) * 2004-08-10 2006-06-08 Wenqing Yao Amido compounds and their use as pharmaceuticals
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
US7825244B2 (en) * 2005-06-10 2010-11-02 Janssen Pharmaceutica Nv Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
WO2007101270A1 (fr) * 2006-03-02 2007-09-07 Incyte Corporation MODULATEURS DE LA 11β-HYDROXYSTEROIDE DESHYDROGENASE DE TYPE 1, COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT ET PROCEDE D'UTILISATION DESDITS MODULATEURS
US20070208001A1 (en) * 2006-03-03 2007-09-06 Jincong Zhuo Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
CA2649677A1 (fr) * 2006-05-01 2007-11-15 Incyte Corporation Urees tetrasubstituees modulateurs de la 11-.beta. hydroxyl steroid deshydrogenase de type 1
CA2652375A1 (fr) * 2006-05-17 2007-11-29 Incyte Corporation Inhibiteurs heterocycliques de la deshydrogenase du steroide hydroxyle 11-.beta. de type 1 et leurs procedes d'utilisation
EP1903038A1 (fr) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft Dérivés N-(1-hetaryl-piperidine-4-yl)-(het)arylamide utilisées comme modulateurs du recepteur EP2
EP1903037A1 (fr) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft Dérivés de 1-[(hétéro)aryl]-3-[hétéroaryl-pipéridine-4-yl]thiourée en tant que modulateurs de récepteurs EP2
SG11202108288YA (en) * 2019-02-01 2021-08-30 Univ Leland Stanford Junior Enpp1 inhibitors and methods of modulating immune response
JP2022526295A (ja) * 2019-03-19 2022-05-24 スティングレイ・セラピューティクス・インコーポレイテッド キノリンおよびキナゾリン化合物およびその使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3637701A (en) * 1969-03-03 1972-01-25 Sandoz Ag Certain nitrate derivatives of 4-aminoquinazolines
DE2121031A1 (en) * 1971-04-29 1972-11-02 Dr. Karl Thomae Gmbh, 7950 Biberach Base-substd quinazolines - thrombocyte aggregation inhibitors
BE793371A (fr) * 1971-12-27 1973-06-27 Sandoz Sa Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces
US3819628A (en) * 1972-07-31 1974-06-25 Sandoz Ag 2-phenyl-4-substituted amino-quinazolines and nitrates thereof
US3838127A (en) * 1972-10-19 1974-09-24 Sandoz Ag 4-(4-(hydroxyalkyl)-1-piperazino)-quinazoline benzoates
GB1417029A (en) * 1973-03-07 1975-12-10 Pfizer Ltd Quinazoline-derived amines

Also Published As

Publication number Publication date
NL7508824A (nl) 1976-01-27
AR215882A1 (es) 1979-11-15
CA1060445A (fr) 1979-08-14
FR2279406B1 (fr) 1980-04-30
FI752104A (fr) 1976-01-26
IE41838B1 (en) 1980-04-09
AR214050A1 (es) 1979-04-30
RO71841A (fr) 1980-08-15
JPS5136469A (fr) 1976-03-27
DK138800C (fr) 1979-04-09
SE420921B (sv) 1981-11-09
BG27744A3 (en) 1979-12-12
DE2530894A1 (de) 1976-02-05
IE41838L (en) 1976-01-25
KE2988A (en) 1979-09-28
YU37155B (en) 1984-08-31
YU184275A (en) 1983-04-27
HK61879A (en) 1979-09-07
JPS5527062B2 (fr) 1980-07-17
FI66182B (fi) 1984-05-31
DK138800B (da) 1978-10-30
YU124181A (en) 1983-04-30
AU8317475A (en) 1977-01-20
DD119046A5 (fr) 1976-04-05
AR212447A1 (es) 1978-07-14
GB1460389A (en) 1977-01-06
AR216046A1 (es) 1979-11-30
IL47625A0 (en) 1975-10-15
RO71840A (fr) 1982-09-09
LU73072A1 (fr) 1977-03-24
AR214049A1 (es) 1979-04-30
SE7508101L (sv) 1976-01-26
FI66182C (fi) 1984-09-10
PH14190A (en) 1981-03-26
RO69296A (fr) 1981-08-30
MY8000108A (en) 1980-12-31
IL47625A (en) 1981-01-30
NL159982C (nl) 1979-09-17
DE2530894C2 (de) 1983-12-22
DK337175A (fr) 1976-01-26
FR2279406A1 (fr) 1976-02-20
US4001422A (en) 1977-01-04
YU124281A (en) 1983-04-30
AR207895A1 (es) 1976-11-08
CH611616A5 (fr) 1979-06-15
AR213407A1 (es) 1979-01-31
BG27086A3 (fr) 1979-08-15
NL159982B (nl) 1979-04-17

Similar Documents

Publication Publication Date Title
JPS50128913A (fr)
FR2279406B1 (fr)
JPS511398U (fr)
JPS50150133U (fr)
JPS50150553A (fr)
AR199089A1 (fr)
AU495844B2 (fr)
JPS5096605U (fr)
AU7474374A (fr)
JPS5116447U (fr)
BG20186A1 (fr)
BG20662A1 (fr)
BG20665A1 (fr)
BG20670A1 (fr)
BG20724A1 (fr)
BG19607A1 (fr)
BG20849A1 (fr)
AU480170A (fr)
BG21661A1 (fr)
AU479987A (fr)
CH612975A5 (fr)
BG21791A1 (fr)
BG22011A1 (fr)
CH576726A5 (fr)
BG22387A3 (fr)

Legal Events

Date Code Title Description
PL Patent ceased